Orbital rhabdomyosarcomas: A review

Area of Science:

• Ophthalmology
• Pediatric Oncology
• Surgical Pathology

Background:

• Rhabdomyosarcoma (RMS) is a malignant soft-tissue tumor, frequently affecting the head and neck in children.
• Orbital RMS accounts for 10% of all childhood RMS cases and is often diagnosed by ophthalmologists.
• While historically grim, survival rates for RMS have dramatically improved.

Purpose of the Study:

• To provide a comprehensive review of primary orbital Rhabdomyosarcoma.
• To summarize recent advancements in diagnosis and treatment over the past decade.
• To present illustrative patient cases managed at the institute.

Main Methods:

• Literature review of primary orbital RMS from the last 10 years.
• Analysis of diagnostic and therapeutic modalities.
• Case study presentation of two patients with orbital RMS.

Main Results:

• Survival rates for RMS have increased from 30% in the 1960s to 90% currently.
• New diagnostic and therapeutic approaches have contributed to improved outcomes.
• Orbital RMS requires specialized ophthalmologic and oncologic management.

Conclusions:

• Primary orbital RMS is a significant pediatric malignancy with improving prognoses.
• Multidisciplinary care and advanced treatments are crucial for successful management.
• Continued research and case reviews are vital for further enhancing patient survival.